Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.04 CHF
300.00 K CHF
486.60 M CHF
24.19 M
About MEDMIX N
Sector
Industry
CEO
René Willi
Website
Headquarters
Zug
ISIN
CH1129677105
FIGI
BBG012NVMDS7
medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. It operates under the Healthcare, and Consumer and Industrial segments. The Healthcare segment focuses on development, production, and marketing dispensers, cartridges, syringes, needles, mixers, and tips for dental applications; syringes, pen injectors, and auto injectors for subcutaneous delivery of biomaterials; and delivery devices for bone repair and tissue treatment. The Consumer and Industrial segment includes dispensers, cartridges, and mixers for two-component adhesives; and sealants for use in the construction, transportation, electronics, infrastructure, general industrial sectors, and DIY market. The company was founded on September 20, 2021 and is headquartered in Zug, Switzerland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDX is 8.80 CHF — it has increased by 0.92% in the past 24 hours. Watch MEDMIX N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MEDMIX N stocks are traded under the ticker MEDX.
MEDX stock has risen by 5.90% compared to the previous week, the month change is a 2.68% rise, over the last year MEDMIX N has showed a −53.34% decrease.
MEDX reached its all-time high on Dec 17, 2021 with the price of 48.44 CHF, and its all-time low was 8.10 CHF and was reached on Dec 20, 2024. View more price dynamics on MEDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDX stock is 2.66% volatile and has beta coefficient of 1.05. Track MEDMIX N stock price on the chart and check out the list of the most volatile stocks — is MEDMIX N there?
Today MEDMIX N has the market capitalization of 355.68 M, it has decreased by −3.00% over the last week.
Yes, you can track MEDMIX N financials in yearly and quarterly reports right on TradingView.
MEDMIX N is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDMIX N revenue for the last half-year amounts to 241.30 M CHF, despite the estimated figure of 244.20 M CHF. In the next half-year revenue is expected to reach 252.70 M CHF.
MEDX net income for the last half-year is 5.20 M CHF, while the previous report showed −7.00 M CHF of net income which accounts for 174.29% change. Track more MEDMIX N financial stats to get the full picture.
Yes, MEDX dividends are paid annually. The last dividend per share was 0.50 CHF. As of today, Dividend Yield (TTM)% is 5.73%. Tracking MEDMIX N dividends might help you take more informed decisions.
MEDMIX N dividend yield was 2.63% in 2023, and payout ratio reached 6.85 K%. The year before the numbers were 2.84% and 176.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 2.66 K employees. See our rating of the largest employees — is MEDMIX N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDMIX N EBITDA is 76.10 M CHF, and current EBITDA margin is 14.06%. See more stats in MEDMIX N financial statements.
Like other stocks, MEDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDMIX N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDMIX N technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDMIX N stock shows the sell signal. See more of MEDMIX N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.